Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis
Open Access
- 8 April 2015
- journal article
- research article
- Published by Elsevier in Mucosal Immunology
- Vol. 8 (6) , 1324-1338
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Adora2b Signaling on Bone Marrow Derived Cells Dampens Myocardial Ischemia-Reperfusion InjuryAnesthesiology, 2012
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- The resurgence of A2B adenosine receptor signalingBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel diseaseProceedings of the National Academy of Sciences, 2009
- Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced ColitisInflammatory Bowel Diseases, 2009
- A2B Adenosine Receptor Gene Deletion Attenuates Murine ColitisGastroenterology, 2008
- Blockade of adenosine A2B receptors ameliorates murine colitisBritish Journal of Pharmacology, 2008
- Recent improvements in the development of A2B adenosine receptor agonistsPurinergic Signalling, 2008
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- The adenosine A2A receptor agonist CGS 21680 fails to ameliorate the course of dextran sulphate-induced colitis in miceInflammation Research, 2007